These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 17161714)
1. A third episode of transfusion-derived vCJD. Wilson K; Ricketts MN Lancet; 2006 Dec; 368(9552):2037-9. PubMed ID: 17161714 [No Abstract] [Full Text] [Related]
2. Transfusion transmission of vCJD: a crisis avoided? Wilson K; Ricketts MN Lancet; 2004 Aug 7-13; 364(9433):477-9. PubMed ID: 15302172 [No Abstract] [Full Text] [Related]
3. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Peden AH; Head MW; Ritchie DL; Bell JE; Ironside JW Lancet; 2004 Aug 7-13; 364(9433):527-9. PubMed ID: 15302196 [TBL] [Abstract][Full Text] [Related]
4. Insights into the management of emerging infections: regulating variant Creutzfeldt-Jakob disease transfusion risk in the UK and the US. Ponte ML PLoS Med; 2006 Oct; 3(10):e342. PubMed ID: 17076547 [TBL] [Abstract][Full Text] [Related]
5. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Hewitt PE; Llewelyn CA; Mackenzie J; Will RG Vox Sang; 2006 Oct; 91(3):221-30. PubMed ID: 16958834 [TBL] [Abstract][Full Text] [Related]
7. Dealing with the uncertain risk of variant Creutzfeldt-Jakob disease transmission by coagulation replacement products. Millar CM; Makris M Br J Haematol; 2012 Aug; 158(4):442-52. PubMed ID: 22775486 [TBL] [Abstract][Full Text] [Related]
8. Transmission of sporadic Creutzfeldt-Jakob disease by blood transfusion: risk factor or possible biases. Puopolo M; Ladogana A; Vetrugno V; Pocchiari M Transfusion; 2011 Jul; 51(7):1556-66. PubMed ID: 21214582 [TBL] [Abstract][Full Text] [Related]
9. Government confirms second case of vCJD transmitted by blood transfusion. Pincock S BMJ; 2004 Jul; 329(7460):251. PubMed ID: 15284140 [No Abstract] [Full Text] [Related]
10. Variant Creutzfeldt-Jakob disease (vCJD). Precautionary measures against the risk of transmission of the agent of vCJD by blood transfusion. Wkly Epidemiol Rec; 2000 Nov; 75(47):377-9. PubMed ID: 11144617 [No Abstract] [Full Text] [Related]
12. Recipients of blood or blood products "at vCJD risk". Bird SM BMJ; 2004 Jan; 328(7432):118-9. PubMed ID: 14726314 [No Abstract] [Full Text] [Related]
13. Variant Creutzfeldt-Jakob disease in a transfusion recipient: coincidence or cause? Chohan G; Llewelyn C; Mackenzie J; Cousens S; Kennedy A; Will R; Hewitt P Transfusion; 2010 May; 50(5):1003-6. PubMed ID: 20230536 [TBL] [Abstract][Full Text] [Related]
14. Fall-out from a possible transfusion-related transmission of vCJD. Brown P Lancet Neurol; 2004 Apr; 3(4):203. PubMed ID: 15039029 [No Abstract] [Full Text] [Related]
15. vCJD and blood transfusion in the United Kingdom. Hewitt P Transfus Clin Biol; 2006 Nov; 13(5):312-6. PubMed ID: 17188541 [TBL] [Abstract][Full Text] [Related]
16. Patients informed of increased risk of vCJD contact. Kmietowicz Z BMJ; 2004 Sep; 329(7468):702. PubMed ID: 15388598 [No Abstract] [Full Text] [Related]
18. [Theoretical risk of vCJD transmission via blood transfusion. Leukocyte and erythrocyte depletion of the transfusion blood is a practice in many countries]. Andersen O Lakartidningen; 2002 Mar; 99(12):1310-4. PubMed ID: 11998162 [No Abstract] [Full Text] [Related]